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ABSTRACT Despite the fact that Ca2 transport into the sarcoplasmic reticulum (SR) of muscle cells is electrogenic, a
potential difference is not maintained across the SR membrane. To achieve electroneutrality, compensatory charge move-
ment must occur during Ca2 uptake. To examine the role of Cl in this charge movement in smooth muscle cells, Ca2
transport into the SR of saponin-permeabilized smooth muscle cells was measured in the presence of various Cl channel
blockers or when I, Br, or SO4
2 was substituted for Cl. Calcium uptake was inhibited in a dose-dependent manner by
5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) and by indanyloxyacetic acid 94 (R()-IAA-94), but not by niflumic acid
or 4,4-dinitrostilbene-2,2-disulfonic acid (DNDS). Smooth muscle SR Ca2 uptake was also partially inhibited by the
substitution of SO4
2 for Cl, but not when Cl was replaced by I or Br. Neither NPPB nor R()-IAA-94 inhibited Ca2
uptake into cardiac muscle SR vesicles at concentrations that maximally inhibited uptake in smooth muscle cells. These
results indicate that Cl movement is important for charge compensation in smooth muscle cells and that the Cl channel
or channels involved are different in smooth and cardiac muscle cells.
INTRODUCTION
In muscle cells, regulation of Ca2 by the sarcoplasmic
reticulum (SR) is essential for normal contractile function.
The finding that the SR membrane in striated muscle is
permeable to a number of ions has led to the conclusion that,
even though a free-Ca2 gradient of 103 or greater exists
between the SR lumen and the cytoplasm in resting muscle
(see Schatzmann, 1989; Somlyo and Himpens, 1989; Kar-
gacin and Kargacin, 1995; Shannon and Bers, 1997), a
membrane potential is unlikely to develop across the SR
membrane (see, for example, Meissner and McKinley,
1982; Garcia and Miller, 1984). This conclusion is sup-
ported by the work of Russell et al. (1979a,b), who used
voltage-sensitive probes but were unable to obtain clear
evidence of a sustained potential across the SR membrane
during Ca2 uptake or release processes (Russell et al.,
1979b). Other, more indirect findings also support this
conclusion. It has been shown, for example, that reconsti-
tuted SR vesicles lacking ion channels are unable to take up
Ca2 unless ionophores allowing compensatory charge
movement are also present in the membrane (Morimoto and
Kasai, 1986; also see Beeler, 1980; Somlyo et al., 1981;
Feher and Fabiato 1990; Tada and Kadoma, 1995; Kourie et
al., 1996a,b). Work from a number of laboratories indicates
that H efflux from the SR is coupled to Ca2 uptake
(Chiesi and Inesi, 1980; Inesi and Hill, 1983; Yu et al.,
1993; Zimniak and Racker, 1978; Beeler, 1980; Yamaguchi
and Kanazawa, 1984, 1985; Levy et al., 1990; da Costa and
Madeira, 1994; see also Hartung et al., 1997). Estimates of
the stoichiometry of this process range from 1H:1Ca2
(Chiesi and Inesi, 1980; Yu et al., 1993; da Costa and
Madeira, 1994) to 3H:2Ca2 (Levy et al., 1990) and
indicate that the SR Ca2 pump, acting in isolation, would
transport net positive charge into the SR. The membrane
potential (50 mV, inside positive; Yu et al., 1993; also see
Zimniak and Racker, 1978; Beeler, 1980; Morimoto and
Kasai, 1986) that develops across the membrane of proteo-
liposomes that contain skeletal muscle SR Ca2 pumps but
are impermeant to other ions is consistent with this conclu-
sion and with a stoichiometry of 1H:1Ca2 for the pump
(Yu et al., 1993). For the overall Ca2 uptake process to be
electrically neutral it would be necessary for additional
charge movement to take place. This charge is likely to be
provided by the movement of K out of, and/or the move-
ment of Cl into, the SR. The SR membranes in striated
muscle have been shown to be permeable to Cl as well as
H, Na and K (Meissner and McKinley, 1982; Fink and
Stephenson, 1987; Yu et al., 1993; see also Kourie et al.,
1996a,b), and a number of ion channels associated with
striated muscle SR (reviewed in Kourie et al., 1996b) and
the endoplasmic reticulum of nonmuscle cells (Clark et al.,
1997) have been characterized electrophysiologically. Al-
though the specific channels or channel types active during
Ca2 uptake have not been elucidated, measurements of the
permeability of skeletal muscle SR vesicles to various ions
indicated that Cl is 50 times more permeable than K
(Kasai and Kometani, 1979). This suggests that Cl influx
is more important than K efflux in maintaining electro-
neutrality during SR Ca2 uptake. This hypothesis is also
consistent with the results of Fink and Stephenson (1987),
who found that the K channel inhibitors tetraethylammo-
nium, 4-aminopyridine, procaine, and decamethonium in-
creased, rather than decreased, the amount of Ca2 that
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could be released from the SR of skinned skeletal muscle
fibers (see discussion by Kourie et al., 1996a,b).
The SR Ca2 pump in smooth muscle is closely related to
the cardiac form of the enzyme (reviewed by Raeymaekers
and Wuytack, 1995), and it is thought that Ca2 regulation
by the SR of smooth muscle is generally similar to that in
striated muscle; however, the involvement of K and Cl in
charge compensation across the SR membrane of smooth
muscle cells during Ca2 uptake has received relatively
little experimental attention. The work reported here was
done using a saponin-skinned isolated cell preparation and
was undertaken to determine if Cl acts as a compensatory
ion during SR Ca2 uptake in smooth muscle and to char-
acterize the Cl-permeant pathway. Our results show that
SR Ca2 uptake can be inhibited by the Cl channel block-
ers 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB)
and indanyloxyacetic acid 94 (R()-IAA-94) and partially
inhibited by the substitution of SO4
2 for Cl. This is
consistent with the hypothesis that Cl movement plays an
important role in charge compensation in smooth muscle
cells during SR Ca2 uptake.
MATERIALS AND METHODS
Smooth muscle cell isolation
Stomachs were excised from rabbits sacrificed with an overdose of phe-
nobarbital. Stomachs were immediately emptied of their contents and
flushed with Hanks’ balanced salt solution (HBSS). A small, healthy piece
of tissue (identified by a mucosa of uniform pink color that loosely covered
the underlying muscle) was cut to a piece 5 cm in diameter. The mucosa
was removed, and the gastric smooth muscle was secured on an O-ring
with dissecting pins to ensure uniform exposure to the enzymatic solution
during the digestion process. The tissue was incubated in a solution of
0.2% collagenase and 0.2% DNase in HBSS for 1 h at 37°C. The tissue was
then triturated in HBSS and transferred to a second solution containing
0.2% protease and 0.2% DNase in HBSS and was incubated for 30 min at
37°C. The tissue was next cut into 1 mm2 pieces and triturated to release
individual cells; the resulting cell suspension was filtered through cheese-
cloth to separate the isolated cells from undigested tissue. EGTA (final
concentration, 2.5 mM) was added to the cell suspension, and the suspen-
sion was centrifuged at 10  g in a benchtop centrifuge for 5 min. The
supernatant was aspirated away, and the cells were resuspended in rigor
buffer and skinned as described previously (Kargacin and Fay, 1987;
Kargacin and Kargacin, 1995) with saponin (50 g/ml) during a 5-min
centrifugation at 10  g. To wash away saponin, the resulting pellet was
resuspended in rigor buffer, incubated for 5 min, then centrifuged (10 g)
for 5 min. After the wash in rigor buffer, the cells were washed three times
in uptake buffer (see below). For each wash, buffer was added to the pellet
from the previous centrifugation, and the resulting cell suspension was
allowed to equilibrate on ice for 10 min before centrifugation (5 min at
10 g), aspiration, and addition of fresh buffer for the next wash. After the
final wash and centrifugation, the cells were resuspended in 500 l to 1 ml
of uptake buffer. This procedure selectively permeabilizes the plasma
membrane and allows measurement of ATP-dependent Ca2 uptake into
the SR of smooth muscle cells (Kargacin and Kargacin, 1995).
Measurement of smooth muscle SR Ca2 uptake
Ca2 uptake into the sarcoplasmic reticulum of the isolated cells was
measured as described previously (Kargacin and Kargacin, 1995). Briefly,
50 l of saponin-permeabilized, isolated cells in uptake buffer was added
to a small chamber on the stage of an inverted microscope, and background
light scatter and fluorescence at 510 nm were measured. Fura-2 (final
concentration 7.5 M) was then added to the chamber. Uptake was
initiated with the addition of (in final concentrations) 12 mM ATP, 12 mM
creatine phosphate (CP), and 19 U/ml creatine phosphokinase (CPK). The
contents of the chamber were continually stirred throughout an experiment
with a small stirrer mounted above the chamber (see Kargacin and Kar-
gacin, 1995). A fluorimeter (SPEX CMX model; Edison NJ), alternating
between 340-nm and 380-nm excitation wavelengths, was used as a light
source for the experiments. Emission was measured at 510 nm (through a
10-nm bandpass filter) with a photomultiplier. Ca2 uptake by the SR of
the skinned cells resulted in a decrease in the 340/380 fluorescence ratio
over the duration of an experiment (see below).
Fura-2 calibration and determination of [Ca2]free,
[Ca2]total, and uptake rate for smooth muscle
experiments
The free Ca2 concentration ([Ca2]free) in the uptake buffer at each time
point was determined from the 340/380 ratio (R) according to the following
equation (Grynkiewicz et al., 1985):
Ca2free KD(Ca2)    	R Rmin
/	Rmax R
 (1)
where Rmax is the fura-2 340/380 fluorescence ratio measured in saturating
Ca2 buffer (containing 95 mM KCl, 20 mM HEPES-K, 2.5 mM CaCl2,
and 10 mM MgCl2; pH 7.0); Rmin is the 340/380 ratio for fura-2 measured
in a Ca2-free solution (25 mM EGTA in uptake buffer); and  is the ratio
of 380-nm fluorescence intensity measured in Ca2-free solution to the
380-nm fluorescence intensity in saturating Ca2 buffer. Kd(Ca2) was 200
nM (Williams et al., 1987). Rmin and Rmax calibrations were made each day
of experimentation to correct for any changes in the relative outputs of
340-nm and 380-nm light from the excitation light source;  was deter-
mined for each lot of fura-2. The total Ca2 concentration ([Ca2]total) in
the chamber at each time point was calculated from [Ca2]free, as described
in Kargacin and Kargacin (1995), using a set of simultaneous equations
that included constants for the binding of Ca2, Mg2, and H by fura-2,
ATP, and CP. Values for the binding constants were taken from Smith and
Martell (1975), Fabiato (1981), and Martell and Smith (1982). For each
experiment, the maximum Ca2 uptake rate (pmol-Ca2/s) was determined
from the negative slope of the [Ca2]total versus time curve:
Velocity 	volume in chamber
Catotal
2 /t (2)
To eliminate errors due to noise inherent in the fluorescence measurements,
the slope was determined from 10–50 data points on the steepest part of an
uptake curve. Fig. 1 illustrates the calculation of maximum uptake rate for
a typical control experiment. Fig. 1 A shows the raw fluorescence data after
correction for background fluorescence and light scatter (recorded as a
decline in 340/380 fluorescence ratio), Fig. 1 B shows the decline in
[Ca2]free in the buffer as a function of time determined from the curve in
Fig. 1 A, using Eq. 1, and Fig. 1 C shows the decline in [Ca2]total in the
buffer during the experiment. The larger open circles in Fig. 1 C show the
data points used to determine the maximum uptake rate for the experiment.
For this experiment, the maximum uptake rate was 7.44 pmol/s. The
maximum rate of SR uptake was dependent upon the amount of SR in a
particular cell preparation (a function of the cell density of the preparation),
but, for control samples, generally fell between 15 and 40 pmole-Ca2/
smg protein when expressed relative to the amount of protein in a cell
preparation. In the work presented below, the results for each separate cell
preparation were expressed as a percentage of the mean rate of uptake in
the control experiments for that preparation, so that results obtained from
different cell preparations could be combined. Unless noted otherwise,
statistical significance was defined as p  0.01, using Student’s t-test.
Results are given as 1 SD. All experiments were conducted at 22°C.
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Solutions for smooth muscle experiments
HBSS contained (in mM) 5 KCl, 0.3 KH2PO4, 138 NaCl, 5.6 D-glucose,
12.5 taurine, and 4 NaHCO3 (pH 7.0). Rigor buffer contained (in mM) 150
K-methanesulfonate, 1 Mg-methanesulfonate, 5 EGTA, 20 piperazine-
N,N-bis(2-ethanesulfonic acid (pH 7.0). Uptake buffer was made using
ultrapure chemicals and double-distilled water and contained (in mM) 100
KX, 10 MgX2, 20 HEPES (pH 7.0) (where X represents Cl
, I, or Br).
For experiments in SO4
2 buffer, KCl and MgCl2 were replaced by 30 mM
K2SO4 and 10 mM MgSO4 (to maintain ionic strength). ATP (K2 salt) and
CP (Na salt) were dissolved in H2O, and the solution was brought to a pH
of 7.0 with KOH. Creatine phosphokinase was then added. Fura-2 was
dissolved in double-distilled water. NPPB, R()-IAA-94, and niflumic
acid were dissolved in 95% ethanol/5% H2O. The final concentration of
ethanol in the experiments with NPPB or R()-IAA-94 did not exceed
1.5%. This concentration of ethanol had no effect on the excitation spectra
of fura-2 or on uptake rates in control experiments. 4,4-Dinitrostilbene-
2,2-disulfonic acid (DNDS) was dissolved in uptake buffer.
D-Glucose, taurine, collagenase IV, protease, EGTA, methanesulfonic
acid, PIPES dipotassium salt, saponin, ATP, CPK, and CP were obtained
from Sigma Chemical Co. (St. Louis, MO). DNase was obtained from
Boehringer-Mannheim (Laval, QC). To minimize Ca2 contamination,
uptake buffers were made from AnalaR grade KCl, and KBr and suprapur
KI obtained from BDH (Toronto, ON) and puriss MgSO4  7H2O, micros-
elect MgCl2  6H2O, MgBr2  6H2O, and HEPES-K
 salt and MgI2 ob-
tained from Fluka (Ronkonkoma, NY). Analytical reagent grade KH2PO4,
NaHCO3, NaCl, and Mg(OH)2, and aristar grade KOH and H2SO4 were
obtained from BDH (Toronto, ON). Fura-2 free acid and DNDS were
obtained from Molecular Probes (Eugene, OR). NPPB was obtained from
ICN (Montreal, QC), and R()-IAA-94 was obtained from RBI (Natick,
MA).
Preparation of cardiac SR vesicles and
measurement of cardiac SR uptake
Canine cardiac SR vesicles were prepared using the method of Chamber-
lain et al. (1983) as described previously (Kargacin and Kargacin, 1994).
Vesicles were stored at 80°C in a storage buffer containing 300 mM
sucrose, 100 mM KCl, 5 mM histidine, and 0.5 mM dithiothreitol (pH 7.1).
The protein concentrations of the vesicle samples used in the experiments
were determined with the Bradford protein assay. Standard curves were
obtained with known concentrations of bovine serum albumin (BSA).
Ca2 uptake into the cardiac SR vesicles was measured as described
previously (Kargacin and Kargacin, 1994) in 3-ml cuvettes in the sample
compartment of a SPEX fluorimeter. Vesicles (275 g total protein)
were added to a cuvette containing 2 ml of vesicle uptake buffer (100 mM
KCl, 4 mM MgCl2, and 20 mM HEPES, pH 7.0). After K2ATP (final
concentration 1.8 mM), CP (final concentration 1.8 mM), CPK (final
concentration 3.1 U/ml), and fura-2 (final concentration 2.9 M) were
added to the cuvette. Uptake was initiated by the addition of Ca2. For the
experiments with NPPB or R()-IAA-94, the blockers were added to the
cuvette before the addition of the vesicles. [Ca2]free was determined from
Eq. 1 with values for Rmax, Rmin, and  obtained with 0-Ca2 (vesicle
uptake buffer containing 25 mM EGTA) and high-Ca2 (vesicle uptake
buffer containing 2.5 mM Ca2) buffers. Vesicle experiments were carried
out at 22°C.
RESULTS
Excitation spectra measurements with NPPB,
R()-IAA-94, and DNDS
The excitation spectra of the uptake buffers containing high
(mM), zero, or intermediate Ca2 concentrations were mea-
sured in the presence and absence of NPPB, R()-IAA-94,
niflumic acid, or DNDS to determine if these agents were
fluorescent. Excitation light was scanned from 300 nm to
400 nm, and emission was measured at 510 nm. Fig. 2 A
shows that NPPB did not contribute to background fluores-
cence. For comparison, the fluorescence intensity from 2.9
M fura-2 was typically 500,000–700,000 cps. Neither
R()-IAA-94 nor niflumic acid detectably altered the back-
ground fluorescence in the absence of fura-2 (result not
shown). DNDS (50 M) caused a small increase in back-
ground fluorescence that was greater at 380-nm excitation
than at 340 nm. At 380-nm excitation, the background
increased from700 cps in the absence of DNDS to2500
cps in the presence of DNDS.
Fura-2 excitation spectra were also measured in the pres-
ence and absence of NPPB, R()-IAA-94, niflumic acid, or
FIGURE 1 Determination of Ca2 uptake rates for isolated cell experiments. (A) 340/380 fluorescence ratio versus time, after correction for background
fluorescence and light scatter. (B) Cafree2 versus time, determined from Eq. 1. (C) Catotal2 versus time, determined from the curve in B and the binding of
Ca2 to various buffer components (see Materials and Methods). The points shown by the larger open symbols were used to determine the maximum rate
of change in [Ca2]total for the experiment. For the experiment shown, the slope was 0.120 M/s, and the volume in the chamber was 62 l, giving a
maximum uptake rate of 7.44 pmol/s.
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DNDS to determine if these compounds altered fura-2 flu-
orescence. As can be seen in Fig. 2 B, NPPB (100 M)
changed the fura-2 excitation spectra in uptake buffer. This
effect was further analyzed by examining the absorbance
spectrum of NPPB. Fig. 2 C shows that NPPB absorbed
more strongly at 380 nm than at 340 nm. Compared to
buffer alone, percentage transmittance was decreased by
60% at 380 nm; at 340 nm, percentage transmittance was
decreased by35% compared to buffer alone (Fig. 2 C). To
correct for the difference in absorbance of NPPB at 340 nm
compared to 380 nm, Rmin and Rmax (see Materials and
Methods) were measured in the presence of NPPB for each
NPPB concentration used. The effect of 75 M R()-
IAA-94 on the excitation spectrum of 3 M fura-2 in uptake
buffer is shown in Fig. 3. Although there was a significant
change in fluorescence intensity at wavelengths below
330 nm, R()-IAA-94 only slightly altered fura-2 fluo-
rescence at 340 nm. Both niflumic acid and DNDS absorbed
more strongly at 340 nm than at 380 nm (results not shown).
Therefore, as was the case with NPPB (see above), Rmin and
Rmax were measured in the presence of each of the blockers
at each concentration used.
Effect of NPPB on smooth muscle SR
Ca2 uptake
NPPB has been used to block sarcolemmal Cl channels in
a variety of tissues (see, for example, Lukacs et al., 1991;
Sorota, 1994). The Ki’s for Cl channel inhibition range
from 0.1 M to 100 M (Lukacs et al., 1991). To examine
the effects of NPPB on smooth muscle SR Ca2 uptake,
NPPB concentrations ranging from 6 M to 100 M were
used. NPPB was added and mixed with the cell suspension
1 min before ATP was added to initiate Ca2 uptake.
Fig. 4 A shows typical traces of [Ca2]free versus time for
a control experiment and an experiment done in the pres-
ence of 20 M NPPB. Uptake rate in the presence of NPPB
was 24% of that measured in the control experiment. In the
control experiment, maximum Ca2 uptake rate was 7.6
pmol/s; in the presence of 20 M NPPB, the maximum
uptake rate was 1.9 pmol/s. Fig. 4 B shows the results from
an experiment on one cell preparation in which the maxi-
mum rate of Ca2 uptake was determined in the presence of
various concentrations of NPPB. For this experiment, up-
take rate was half-maximum in the presence of 10 M
NPPB. When results from five similar experiments were
combined, the uptake rate was half-maximum with 15 M
NPPB. The uptake rate was reduced to 12  7% (n  4) of
control at NPPB concentrations  75 M (see Table 1).
Effect of R()-IAA-94 on smooth muscle SR
Ca2 uptake
Indanyloxyacetic acid (IAA) derivatives (at concentrations
ranging from 1 M to 200 M) have been found to block
FIGURE 2 (A) Effect of 100 M NPPB on background fluorescence over excitation wavelengths between 300nm and 400 nm. F, Background
fluorescence in uptake buffer alone. E, Background fluorescence in uptake buffer containing 100 M NPPB. (B) Excitation spectra of 3.0 M fura-2 with
and without 100 M NPPB. F, Fura-2 fluorescence in uptake buffer. E, Fura-2 fluorescence when 100 M NPPB was added to uptake buffer. (C)
Absorbance spectrum of 100 M NPPB in uptake buffer at excitation wavelengths of 300–400 nm and 480–530 nm. In A and B emission was measured
at 510 nm through a 10-nm bandpass filter.
FIGURE 3 Excitation spectra of 2.9 M fura-2 with and without 75 M
R()-IAA-94. Œ, Fura-2 fluorescence in uptake buffer. ‚, Fura-2 fluores-
cence when 75 M R()-IAA-94 was present in the uptake buffer.
Emission was measured at 510 nm through a 10-nm bandpass filter.
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plasmalemmal and intracellular membrane Cl channels in
a variety of tissues, including kidney, trachea, and heart
(see, for example, Landry et al., 1989; Redhead et al., 1992;
Weber-Schu¨rholz et al., 1993; Reeves and Gurich, 1994;
Sorota, 1994; Takenaka et al., 1996; Clark et al., 1997).
These compounds appear not to have been tested on smooth
muscle SR Cl channels, however. Experiments on sapo-
nin-permeabilized smooth muscle cells demonstrated a
dose-dependent decrease in Ca2 uptake with increasing
concentrations of R()-IAA-94. Fig. 5 shows the results of
experiments in which the rate of Ca2 uptake was measured
in the absence and the presence of R()-IAA-94. The
maximum uptake rate in the control experiment was 7.0
pmol/s. In the presence of 47 M R()-IAA-94 this rate
was reduced to 2.0 pmol/s. The inhibitory effect of R()-
IAA-94 was dose dependent. Combined results from six cell
preparations showed that the uptake rate was half-maximum
at [R()-IAA-94] equal to 46 M; [R()-IAA-94]  190
M reduced the uptake rate to 7  9% (n  9) of control
(see Table 1).
SR Ca2 uptake in smooth muscle in the
presence of niflumic acid and DNDS
Niflumic acid and stilbene derivatives have been used to
block Cl channels in a variety of tissues. Niflumic acid at
a concentration of 30 M had no detectable effect on SR
Ca2 uptake in smooth muscle cells (Table 1). The stilbene
derivative DNDS was also without effect on SR Ca2
uptake at concentrations as high as 300 M and incubation
times with the cells of up to 30 min. In control experiments,
maximum uptake rates ranged from 4.45 to 4.8 pmol/s; in
the presence of 300 M DNDS, maximum uptake rates
ranged between 4.55 and 4.65 pmol/s.
Smooth muscle SR Ca2 uptake in the presence
of I, Br, or SO4
2
Smooth muscle SR Ca2 uptake was also examined when
the Cl in the uptake buffer was completely replaced by I,
Br, or SO4
2 (results are summarized in Table 1). Uptake
rates in I or Br buffers were not significantly different
from those measured in Cl buffer. In I uptake buffer, the
maximum uptake rate was 90  16% (n  4) of the mean
maximum uptake rate in control experiments; in Br uptake
buffer, the maximum uptake rate was 102  20% (n  4)
of the mean maximum uptake rate in control experiments.
The maximum rate of SR Ca2 uptake was reduced when
Cl in the uptake buffer was replaced with SO4
2. The
maximum uptake rate in SO4
2 buffer was 80  11% (n 
5) of the mean maximum uptake rate in control experiments.
This was significant at p  0.03.
FIGURE 4 Inhibition of smooth muscle SR Ca2 uptake by NPPB. (A) Comparison of uptake rates in control (F) and in the presence of 20 M NPPB
(E). The slopes of the lines are the maximum rates of uptake determined from the curves. The uptake rate in the control experiment was 7.6 pmol/s; the
uptake rate in the presence of NPPB was 1.9 pmol/s. (B) Concentration dependence of the inhibition of SR Ca2 uptake with NPPB for one cell preparation.
The solid line is an exponential curve fit to the data points; half-maximal inhibition was at 10 M NPPB.
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The inhibitory effect of NPPB on SR Ca2 uptake was
also seen in buffers in which Cl was replaced with I or
SO4
2. In one experiment, the uptake rate in SO4
2 buffer
containing 96 M NPPB was 1.5% of the maximum uptake
rate measured in SO4
2 buffer without NPPB. This percent-
age inhibition was similar to that measured in Cl buffers
(see Table 1). A similar result was obtained when NPPB
was added to I uptake buffer.
Ca2 uptake by canine cardiac SR vesicles in the
presence of NPPB or R()-IAA-94
In previous electrophysiological studies, Townsend and
Rosenberg (1995) showed that NPPB blocked an SR Cl
channel from porcine cardiac myocytes. This block, how-
ever, appeared to be from the lumenal side of the SR
membrane. Weber-Schu¨rholz et al. (1993) reported that
R()-IAA-94 inhibited a Cl channel that appeared to be
present in the sarcolemmal but not the SR membrane of
skeletal muscle. Because both NPPB and R()-IAA-94
inhibited Ca2 uptake into smooth muscle SR in the func-
tional studies reported here, the effects of these blockers on
Ca2 uptake into canine cardiac SR vesicles was examined.
Neither of these agents, at concentrations that almost com-
pletely inhibited smooth muscle SR uptake, had a signifi-
cant effect on the rate of Ca2 uptake into cardiac SR
vesicles. Ca2 uptake in the presence of 100 MNPPB was
94  35% (n  8) of the mean maximum uptake rate in
control experiments. R()-IAA-94 also failed to inhibit
cardiac SR Ca2 uptake (in the presence of 226 M R()-
IAA-94, the maximum uptake rate was 98.3% of the control
rate).
DISCUSSION
In previous work (Kargacin et al., 1988; Kargacin and
Kargacin, 1994; 1995) it was shown that the methods em-
ployed in the present study could be used to study Ca2
uptake into the SR of isolated, saponin-permeabilized
smooth muscle cells and striated muscle SR vesicles. In the
work on smooth muscle (Kargacin and Kargacin, 1995), it
was shown that uptake was Ca2 and ATP dependent and
could be blocked by thapsigargin. Uptake was not inhibited
by the mitochondrial blockers FCCP or azide.
In the present study, it was found that SR Ca2 uptake in
smooth muscle could be almost completely blocked by the
Cl channel blockers NPPB and R-IAA-94. On the other
hand, neither the stilbene derivative DNDS nor niflumic
acid had any measurable effects on SR Ca2 uptake. Max-
imum uptake rate was also partially reduced by the replace-
ment of Cl by SO4
2, but not in I or Br uptake buffers.
A functional assay such as the one used in the present study
has the advantage that it can provide information about the
properties of the anion-permeant pathway or pathways that
are important for charge compensation in vivo that cannot
be determined solely from the study of single channels in
isolation. However, because the movement of Ca2 rather
than Cl is measured, one must consider the possibility that
the ion channel inhibitors acted on the SR Ca2 pump or at
other sites on the SR membrane rather than on Cl chan-
nels. To our knowledge, there have been no reports of a
direct action of NPPB or R()-IAA-94 on the SERCA
Ca2-ATPases in any tissue. The SERCA2b Ca2 pump
found in smooth muscle is identical for most of its amino
sequence to the SERCA2a Ca2 pump of cardiac muscle.
The two isoforms differ only in the C-terminal region,
where a 4 amino acid segment of SERCA2a is replaced by
a 49 amino acid hydrophobic segment in SERCA2b (re-
viewed in Raeymaekers and Wuytack, 1995). Because
NPPB and R()-IAA-94 both inhibited Ca2 uptake in
smooth but not in cardiac muscle, it seems unlikely that the
inhibitory actions of these agents were due to a direct
inhibition of the Ca2 pump, unless both agents act non-
specifically on the unique amino acid segment of the SR
Ca2-ATPase of smooth muscle. It might also be argued
that the different effects of NPPB and R()-IAA-94 on
smooth and cardiac muscle SR Ca2 uptake were the result
of comparing experiments using SR vesicles with those
using permeabilized isolated cells. In preliminary experi-
ments (S. V. Phillips, G. J. Kargacin, and M. E. Kargacin)
it was found that SR Ca2 uptake in isolated rat cardiac
myocytes was not inhibited by either of the Cl channel
blockers, a result consistent with that obtained with cardiac
SR vesicles. Lukacs et al. (1991) found that NPPB can act
directly on membranes as a proton ionophore at concentra-
tions (25 M or greater) that have been used to block Cl
channels, and high concentrations of IAA (500 M to 1
mM) have been shown to open K channels in smooth
muscle (Toma et al., 1996). If the effect of NPPB on smooth
muscle SR Ca2 uptake were due to its protonphoric prop-
FIGURE 5 Inhibition of smooth muscle SR Ca2 uptake by R()-IAA-
94. (A) Comparison of uptake rates in control (F) and in the presence of 47
M R()-IAA-94 (E). The slopes of the lines are the maximum rates of
uptake determined from the curves. The uptake rate in the control exper-
iment was 7.0 pmol/s; the uptake rate in the presence of R()-IAA-94 was
2.0 pmol/s.
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erties, we would have expected to see a similar effect on the
cardiac muscle SR vesicles. This, however, was clearly not
the case. The concentration of R()-IAA-94 (200 M) that
had a maximum inhibitory effect on SR Ca2 uptake in
smooth muscle was less than that (500 M) used by Toma
et al., (1996) to open K channels. Furthermore, if R()-
IAA-94 had opened a K-permeant pathway in the SR, we
would have expected to see an increase rather than a de-
crease in the rate of Ca2 uptake in the smooth muscle cells.
When the effects of both Cl channel blockers are taken
together, our results appear to be most consistent with the
interpretation that they acted on an anion channel in the
smooth muscle SR.
Because smooth muscle SR Cl channels have received
relatively little experimental attention, prior information
was not readily available to assess the likely action of any of
the Cl channel blockers on SR Ca2 uptake in smooth
muscle. As noted above, Townsend and Rosenberg (1995)
showed that NPPB (10–50 M; on the luminal side of the
SR membrane) blocked an SR Cl channel from porcine
cardiac myocytes. Luminal NPPB (but not NPPB applied to
the cytoplasmic side of the SR membrane) decreased chan-
nel open probability with a Ki of 52.6 M (Townsend and
Rosenberg, 1995). This result is consistent with our finding
that SR Ca2 uptake in cardiac muscle was not blocked by
NPPB applied to the outside (cytoplasmic side) of SR
vesicles. If the Cl channels in the cardiac SR membrane
are similar to those found in skeletal muscle, our results on
cardiac muscle are in agreement with those of Weber-
Schu¨rholz et al. (1993), who did not find R()-IAA-94-
sensitive channels in skeletal muscle SR membranes. Our
results on smooth muscle are consistent with the presence of
an anion channel in the SR membrane that is sensitive to
both NPPB and R()-IAA-94. Although we cannot com-
pletely rule out the possibility that the properties of the
Cl-permeant pathway we have determined represent the
combined properties of more than one anion channel, our
results could be explained by the presence of a Cl channel
similar to the channel recently described by Clark et al.
(1997) that is found in the endoplasmic reticulum of rat
brain. This channel was blocked by NPPB at concentrations
ranging from 10 M to 100 M and by R()-IAA-94 over
a concentration range between 25 M and 200 M (Ki for
block  35 M). NPPB blocked from either side of the
membrane; R()-IAA-94 blocked from the cytoplasmic
side of the membrane. Consistent with our results, the
channel was insensitive to niflumic acid and was permeant
to Br. Unlike our result with DNDS, the rat brain channel
was blocked by the stilbene derivative 4,4-diisothiocyana-
tostilbene-2,2-disulfonic acid (DIDS), however.
Because we were able to almost completely inhibit SR
Ca2 uptake in smooth muscle with either NPPB or R()-
IAA-94, it seems reasonable to conclude that Cl move-
ment plays a more important role than K movement in
charge compensation during Ca2 uptake. This is consistent
with the suggestion by Kourie et al. (1996a,b) that Cl
movement is also more important in striated muscle. The
rate at which Ca2 must be removed from the cytoplasm
after the contraction of striated muscle cells is much greater
than that required in smooth muscle (reviewed by Raey-
maekers and Wuytack, 1995), however. It therefore seems
possible that the Cl channel or channels involved are
different in the two muscle types. In this light, the fact that
our results point to a Cl channel in smooth muscle SR that
resembles one found in the endoplasmic reticulum makes it
of interest to note that the isoforms of a number of proteins
that are found in smooth muscle cells more closely resemble
those found in nonmuscle cells than they do those found in
the more highly specialized cells of cardiac and skeletal
muscle.
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